window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Central Nervous System

  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Owlstone Medical awarded up to $49.1 million from ARPA-H to develop at-home multi-cancer early detection tests

    Owlstone Medical has received an award of up to $49.1 [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development

    Alto Neuroscience receives FDA Fast Track designation for ALTO-101 to treat cognitive impairment in schizophrenia

    Alto Neuroscience has received FDA Fast Track designation for its [...]

    May 5, 2026
  • Biotech & Pharma Business,Central Nervous System,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Therapeutic Areas

    Neuraxpharm launches next-generation oral fumarate Riulvy for multiple sclerosis in Germany

    Neuraxpharm Group has launched Riulvy (tegomil fumarate) in Germany, marking [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Levicept to present Phase 2 LEVI-04 data showing bone marrow lesion and pain reduction at ACR Convergence 2025

    Levicept Ltd will present new findings from its Phase 2 [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gene therapy AMT-130 slows Huntington’s disease progression in early trial

    A gene therapy developed by uniQure appears to slow progression [...]

    May 5, 2026
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics

    Bristol Myers Squibb to launch Cobenfy in the UK at US list price for adults with schizophrenia

    Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium [...]

    May 5, 2026
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Therapeutic Areas

    Servier acquires Kaerus drug candidate for Fragile X syndrome, the most common genetic cause of autism

    Servier has acquired KER-0193 from Kaerus Bioscience, gaining a potential [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    New study shows covariate adjustment improves trial precision for pain, mood and fatigue outcomes

    A study published in the Journal of Pain has shown [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Drug Discovery & Development

    $2.5M awarded to fuel breakthrough research into tau-driven neurodegenerative diseases

    The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Preclinical study shows evenamide targets schizophrenia pathology in the hippocampus

    Newron Pharmaceuticals has highlighted new preclinical findings published in Neuropsychopharmacology [...]

    May 5, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Robotic gastrectomy shows benefits over laparoscopic surgery in gastric cancer
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Leicester clinic offers Galleri blood test following NHS cancer trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Lonza launches rapid custom media service for early bioprocess development
    Categories: Drug Delivery & Formulation, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top